Research Article
An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Two Periods, Crossover, Single Dose, Bioequivalence Study of Olmesartan medoxomil/Hydrochlorothiazide 20 mg/12.5 mg Coated Tablets of Abbott and Olmetec plus® (Olmesartan medoxomil/Hydrochlorothiazide) 20 mg/12.5 mg Coated Tablets of Daiichi-Sankyo in Healthy, Adult, Human Subjects Under Fasting Condition
- Arjun Arumugam O1*, Geethalakshmi G1
, Srinivas G1
, Hurtado-Colorado Karen2
, Higuera Maria Juliana2
, Gavino-Gutiérrez ArquÃmedes
M3
, Lara Claudia4
, Cereceda Gabriel5
, Leon Isaac5
, Tagle Arturo Ruiz5
, Gonzalez Camila5
, Pinto Deny5
, Echeverria Patricia5
, Lobos
MarÃa Francisca5
, Calderon Sebastián5
, Sosa MarÃa del Milagro5
, Sasso Jaime5
, Kramm Karina5
, Jimenez Julio5